World ‘better prepared’ for COVID variants: BioNTech CEO to AFP
The world is becoming “better prepared” to deal with future variants of the coronavirus, the CEO and co-founder of German vaccine-maker BioNTech told AFP on Thursday, as the company works on an Omicron-specific shot.
“We will have to get used to the fact that we will have to live with the virus for the next 10 years,” said Ugur Sahin, whose company developed the first mRNA vaccine against the virus with US pharma giant Pfizer. “There will always be new variants, but we are always learning more and are becoming better prepared.”
No need yet to adapt Pfizer vaccine for Covid variants: BioNTech chief
World ‘better prepared’ for COVID variants: BioNTech CEO to AFP (2022, February 17)
retrieved 17 February 2022
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.